Keyword: Genentech

Atara hires ex-Genentech SVP to lead R&D, Semma names former Novartis CAR-T developer as CEO, and GSK's CFO heads for the exit.

Genentech and Lodo Therapeutics signed a drug discovery collaboration worth nearly $1 billion, focused on deriving products from DNA found in soil.

Berger Atara joins after seven years at Roche’s Genentech, during which time he had a hand in the approval of drugs including Tecentriq.

GSK steals Roche exec to lead R&D deal-making, Sanofi CFO Contamine will retire, Novartis poaches Amgen's CMO, FDA CDER director jumps to AZ.

Emma Walmsley continues her R&D metamorphosis at GlaxoSmithKline with another big new hire in the guise of Kevin Sin.

Constellation raised $100 million that will bankroll a cancer epigenetics asset through the clinic.

Genentech scientists used an antibody to kill E. coli bacteria by blocking the enzyme BamA.

Kapeller departs having helped put virtual drug discovery on the map and land deals with Celgene, Genentech and Gilead.

Roche's antibody RG7716 in diabetic macular edema could be a threat to current blockbuster VEGF drugs used for the disease.

Just a few days after the FDA placed a clinical hold on its lead cell therapy for cancer, Bellicum has named an ex-Genentech executive as its CMO.